
Sofinnova et al. back €27m series-C for Limflow
A consortium of investors has injected €27m in a series-C funding round for French developer of peripheral endovascular technology Limflow.
Latest News
Essling backs Evolucare Group
GP invests in the software company via Essling Expansion, a fund that recently held a first close
Naxicap-backed BVA bolts on Doxa
BVA expects to become one of the main market research groups in Europe and reach revenues of €200m
Palamon announces roll-over investment into Ober Scharrer
GP sold Ober Scharrer to Nordic last year, generating a 3.6x return on its original investment
Augmentum leads £150m debt and equity round for Iwoca
NIBC and existing investors including Prime also took part in the round for the SME lender
Back to Top